GlassScriptPhysician profile
Leann D Hess
NPI 1972975902
$4,255.67
in general payments reported to CMS, 2019-2025
22 companies · $801 in 2025
The $801 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.38 · 2022: $897 · 2023: $1,610 · 2024: $848 · 2025: $801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,215 · Education: $44.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,215.14 |
| Education | $44.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,158.86 | 2022-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $581.38 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Amgen INC. | $533.98 | 2022-2025 | Tezspire, Tavneos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $438.20 | 2021-2025 | Ofev |
| Electromed, INC. | $259.05 | 2022-2025 | Smartvest |
| Grifols USA, LLC | $226.79 | 2022-2024 | Prolastin-C Liquid |
| Insmed, INC. | $186.91 | 2023-2025 | Arikayce, Brinsupri |
| Inspire Medical Systems, INC. | $167.58 | 2024-2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $150.91 | 2022-2024 | Opsumit, Uptravi |
| Baxter Healthcare | $117.72 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Mylan Specialty L.P. | $107.44 | 2022-2023 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $76.73 | 2022-2025 | Dupixent |
| Philips North America LLC | $42.90 | 2023 | |
| Lilly USA, LLC | $42.47 | 2021 | |
| Genentech USA, INC. | $29.80 | 2024 | Xolair |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $26.73 | 2023 | |
| Sanofi Pasteur INC. | $21.28 | 2023 | |
| Jazz Pharmaceuticals INC. | $20.98 | 2022 | |
| Tactile Systems Technology INC | $19.69 | 2024 | Flexitouch Plus, Entre Plus |
| Zoll Respicardia, INC. | $19.25 | 2024 | Remede System |
| Genzyme Corporation | $16.49 | 2025 | |
| Gilead Sciences, INC. | $10.53 | 2023 | Veklury |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leann Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.